ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $7,170,000 | +15.6% | 425,000 | -90.0% | 0.35% | +38.5% |
| Q1 2017 | $6,205,000 | +2.8% | 4,250,000 | 0.0% | 0.25% | -19.7% |
| Q4 2016 | $6,035,000 | -67.2% | 4,250,000 | -59.5% | 0.31% | -61.1% |
| Q3 2016 | $18,375,000 | +2.3% | 10,500,000 | 0.0% | 0.81% | -6.9% |
| Q2 2016 | $17,955,000 | -3.6% | 10,500,000 | +7.7% | 0.87% | -45.6% |
| Q3 2015 | $18,623,000 | -46.5% | 9,750,000 | +30.0% | 1.60% | -32.7% |
| Q2 2015 | $34,800,000 | +6.2% | 7,500,000 | 0.0% | 2.37% | +1.2% |
| Q1 2015 | $32,775,000 | – | 7,500,000 | – | 2.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |